Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil

Chryseobacterium indologenes is a non-glucose-fermenting Gram-negative bacillus. This emerging multidrug resistant opportunistic nosocomial pathogen can cause severe infections in neonates and immunocompromised patients. This study aimed to present the first detailed draft genome sequence of a multi...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine Vol. 9; p. 931379
Main Authors: Damas, Marcelo Silva Folhas, Ferreira, Roumayne Lopes, Campanini, Emeline Boni, Soares, Gabriela Guerrera, Campos, Leslie Camelo, Laprega, Pedro Mendes, Soares da Costa, Andrea, Freire, Caio César de Melo, Pitondo-Silva, André, Cerdeira, Louise Teixeira, Cunha, Anderson Ferreira da, Pranchevicius, Maria-Cristina da Silva
Format: Journal Article
Language:English
Published: Frontiers Media S.A 28-07-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chryseobacterium indologenes is a non-glucose-fermenting Gram-negative bacillus. This emerging multidrug resistant opportunistic nosocomial pathogen can cause severe infections in neonates and immunocompromised patients. This study aimed to present the first detailed draft genome sequence of a multidrug-resistant C. indologenes strain isolated from the cerebrospinal fluid of an infant hospitalized at the Neonatal Intensive Care Unit of Brazilian Tertiary Hospital. We first analyzed the susceptibility of C. indologenes strain to different antibiotics using the VITEK 2 system. The strain demonstrated an outstanding resistance to all the antibiotic classes tested, including β-lactams, aminoglycosides, glycylcycline, and polymyxin. Next, C. indologenes was whole-genome-sequenced, annotated using Prokka and Rapid Annotation using Subsystems Technology (RAST), and screened for orthologous groups (EggNOG), gene ontology (GO), resistance genes, virulence genes, and mobile genetic elements using different software tools. The draft genome contained one circular chromosome of 4,836,765 bp with 37.32% GC content. The genomic features of the chromosome present numerous genes related to cellular processes that are essential to bacteria. The MDR C. indologenes revealed the presence of genes that corresponded to the resistance phenotypes, including genes to β-lactamases ( bla IND– 13 , bla CIA– 3 , bla TEM– 116 , bla OXA– 209 , bla VEB– 15 ), quinolone ( mcb G), tigecycline ( tet (X6)), and genes encoding efflux pumps which confer resistance to aminoglycosides ( Ran A/ Ran B), and colistin ( Hly D/ Tol C). Amino acid substitutions related to quinolone resistance were observed in GyrA (S83Y) and GyrB (L425I and K473R). A mutation that may play a role in the development of colistin resistance was detected in lpxA (G68D). Chryseobacterium indologenes isolate harbored 19 virulence factors, most of which were involved in infection pathways. We identified 13 Genomic Islands (GIs) and some elements associated with one integrative and conjugative element (ICEs). Other elements linked to mobile genetic elements (MGEs), such as insertion sequence (ISEIsp1), transposon (Tn5393), and integron (In31), were also present in the C. indologenes genome. Although plasmids were not detected, a ColRNAI replicon type and the most resistance genes detected in singletons were identified in unaligned scaffolds. We provided a wide range of information toward the understanding of the genomic diversity of C. indologenes , which can contribute to controlling the evolution and dissemination of this pathogen in healthcare settings.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors have contributed equally to this work
Edited by: Xiaojiong Jia, Harvard Medical School, United States
Reviewed by: Polly Soo Xi Yap, Monash University Malaysia, Malaysia; Joshy M. Easow, Sri Balaji Vidyapeeth University, India
This article was submitted to Infectious Diseases – Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2022.931379